Formaldehyde is a chemical commonly used in hospitals as a tissue preservative; histopathology laboratory personnel are therefore among the workers most heavily exposed to formaldehyde. This study measured the formaldehyde exposure through ambient and personal air sampling, assessed the symptoms of poor health as well as estimating the health risk among hospital workers. We conducted a comparative cross-sectional study of both histopathology laboratory (exposed) and administration (nonexposed) workers in four hospitals in the Klang Valley, Selangor, Malaysia. Ambient and personal exposure to formaldehyde was measured using the OSHA 52 and NIOSH 2541 methods, respectively. The 8-hr time-weighted-average formaldehyde concentration was higher in exposed areas (0.25 ± 0.11 ppm) than nonexposed areas (0.08 ± 0.02 ppm). Histopathology workers were exposed to between 140% and 480% higher concentrations of formaldehyde than administration workers. Personal exposure was highest during grossing tasks (0.797 ± 0.436 ppm). A total of 67% of the exposed workers exhibited the same ten health symptoms related to formaldehyde exposure, and 57% of the nonexposed workers reported similar symptoms at their current workplace. Notably, symptoms of eye irritation, headache, drowsiness, and chest tightness were significantly more prevalent (p < 0.05; chi square and Fisher's exact tests) among the exposed workers than the nonexposed workers. Among those with symptoms, 37% of the exposed workers, and 16% of the nonexposed workers believed that the symptoms were related to their current working environment. The noncancer effect of formaldehyde from air inhalation poses a potential risk of eye irritation among exposed workers. The cancer risk was not significant in both groups. Formaldehyde levels and symptoms of poor health were significantly higher among the exposed group.
Electronic cigarette (EC) is a device that imitates conventional cigarettes, which vaporizes a solution, with or without nicotine. This study evaluates the nicotine levels in EC refill solutions, its release in aerosols and comparison to the amount stated on the label. Seventy-two (72) different EC refill solutions were obtained from local shops in Selangor, Malaysia consisting of 40 nicotine-containing (3-12 mg) and 32 nicotine-free (0 mg) solutions. Aerosols were obtained by using an air tight syringe connected to an EC device to draw aerosol through an XAD-4 sorbent tube that trapped the nicotine. Nicotine in solution and aerosol samples are analyzed using gas chromatography-mass spectrometry equipment. Quantified nicotine in 40 nicotine-containing solutions ranged from 0.224-17.306 mg/mL. Nicotine is detected in 3 of the 32 nicotine-free solutions. Percentage of nicotine released into aerosols from refill solutions varied from 0.54%-28.2%. Out of the 40 samples, thirty-two (32) had nicotine content that violated by more than ±10% from the value on the label. In comparing the labels, 19 samples have 0.3%-77% higher nicotine level and 13 samples have 0.2%-96.3% lower nicotine content. The inconsistency between the labelled and true levels of nicotine content indicates that commercial information may be misleading. The presence of nicotine in the nicotine-free refill solutions and higher nicotine content in aerosols may be addictive and may have negative health effects on users.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.